In this study, the majority of patients in the high level JAK2 V617F (>15% JAK2) positive group were diagnosed with PV, while in the low level JAK2 V617F positive group (≤15% of JAK2), the most frequent MPN was ET (Table 2). Here, JAK2 is linked to myeloproliferative neoplasm.